Core Points - FOXO Technologies Inc. has designated a new series of preferred stock, Series E Cumulative Redeemable Secured Preferred Stock, with a stated value of $25.00 per share and a 2.5% cash dividend paid semi-annually [1] - The Series E Preferred Stock will serve as both an acquisition currency and a capital raising security, aimed at supporting the company's acquisition strategy and enhancing long-term value for stockholders [2] - FOXO operates three subsidiaries, including a critical access hospital and a behavioral health facility, indicating its involvement in the healthcare sector [3] Financial Details - The Series E Preferred Stock includes a 5.0% per annum common stock dividend paid semi-annually and a security interest in the stock of FOXO's acquisition vehicle [1] - The company intends to publicly list the Series E Preferred Stock with its own trading symbol at an appropriate time [2] Company Overview - FOXO Technologies Inc. focuses on improving human health and lifespan through biotechnology and innovative product solutions [4] - The company operates in the healthcare industry, with subsidiaries that provide critical access healthcare and behavioral health services [3]